文献速递泌尿系结石肾癌与肾肿瘤

近端输尿管病变的治疗性活体供肾切除术:纵向病例系列

Therapeutic Living Donor Nephrectomy for Proximal Ureteral Pathology: A Longitudinal Case Series.
PubMed 文献 · Urology · 2022-05-09

该回顾性病例系列纳入7例因近端输尿管病变及结石病而选择肾切除术的患者,行治疗性活体供肾切除术(TLDN)。供者平均57.9天后手术,受者随访平均40.1个月,移植物及受者存活率100%,无输尿管狭窄或结石复发;作者认为该做法安全,已决定肾切除的合适患者应接受相关咨询。

要点

  • 7例近端输尿管病变供者行TLDN,其中6例合并肾结石或输尿管结石。
  • 受者无移植肾功能延迟恢复,移植物及受者存活率100%,无狭窄或结石复发。
  • 作者认为已决定肾切除的合适患者应接受TLDN咨询,供者未来可获等待名单优先权。

核心结论

  • 作者认为这是首个系列,显示近端输尿管狭窄、即使合并结石病的患者可捐肾用于移植。
  • 作者认为受者结局提示该做法安全,已决定肾切除的合适患者应接受该机会的咨询。
  • 作者指出捐肾患者若未来需要肾移植,可获得等待名单优先权。

研究设计与样本

  • 回顾性病例系列,纳入7例有近端输尿管病变和结石病的治疗性供者。
  • 收集患者特征、供者评估、手术细节及供受者结局。

主要发现

  • 7例供者均有近端输尿管病变,其中6例有肾结石或输尿管结石。
  • 选择肾切除后至TLDN的平均时间为57.9天。
  • 受者无移植肾功能延迟恢复,移植物及受者存活率均为100%。
  • 平均随访40.1个月(范围8-131),最近随访平均肌酐为1.08 mg/dL。
  • 受者无输尿管狭窄或结石复发。

临床怎么用

  • 作者认为已决定肾切除的合适患者应接受治疗性活体供肾切除术的咨询。
  • 作者指出捐肾患者若未来需要肾移植,可获得等待名单优先权。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To raise awareness that patients with proximal ureteral stricture who elect for nephrectomy can consider donating the kidney. We present a series of patients undergoing therapeutic living donor nephrectomy (TLDN), a scenario in which a patient undergoing nephrectomy for an underlying medical problem donates the kidney to a person with end-stage renal disease. This practice is underutilized, and only a single TLDN with proximal ureteral stricture has been previously described. We aim to help define the indications, risks, and benefits for patients. METHODS: This is a retrospective case series of seven therapeutic donors with proximal ureteral pathology and stone disease. Patient characteristics, donor work up, operative details, and donor and recipient outcome were collected. RESULTS: All seven donors had proximal ureteral pathology, and six of the seven had nephrolithiasis or ureterolithiasis. After electing for nephrectomy, the mean time to TLDN was 57.9 days. No recipients experienced delayed graft function . Mean follow up was 40.1 months (range 8-131), and the most recent follow-up mean creatinine was 1.08 (mg/dL). Graft and recipient survival is 100%. No recipients developed recurrence of ureteral stricture or stones. CONCLUSION: This is the first series demonstrating patients with proximal ureteral stricture, even with concomitant stone disease, may donate kidneys for transplantation. Recipient outcomes suggest this practice is safe, and appropriately selected patients that have already elected for nephrectomy should receive counseling about this opportunity. Importantly, patients who donate a kidney receive waiting list priority if they ever need a kidney transplant in the future.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Freise J, Nunez M, Chi T, et al. Therapeutic Living Donor Nephrectomy for Proximal Ureteral Pathology: A Longitudinal Case Series. Urology. 2022. PMID: 35550384. doi:10.1016/j.urology.2022.04.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。